Callahan MM - Search Results

1

A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor.

Schwartz JL, Kovalevsky G, Lai JJ, Ballagh SA, McCormick T, Douville K, Mauck CK, Callahan MM. Schwartz JL, et al. Among authors: callahan mm. Sex Transm Dis. 2008 Apr;35(4):414-9. doi: 10.1097/OLQ.0b013e318162c4d8. Sex Transm Dis. 2008. PMID: 18362865 Clinical Trial.

2

A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel.

Cohen JA, Brache V, Foster J, Cochon L, Callahan M, Schwartz J. Cohen JA, et al. Sex Transm Dis. 2013 Jun;40(6):476-81. doi: 10.1097/OLQ.0b013e3182927ab1. Sex Transm Dis. 2013. PMID: 23677021 Clinical Trial.

3

Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study.

Schwartz JL, Mauck C, Lai JJ, Creinin MD, Brache V, Ballagh SA, Weiner DH, Hillier SL, Fichorova RN, Callahan M. Schwartz JL, et al. Contraception. 2006 Aug;74(2):133-40. doi: 10.1016/j.contraception.2006.02.008. Epub 2006 May 2. Contraception. 2006. PMID: 16860051 Clinical Trial.

4

Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.

Mauck CK, Weiner DH, Ballagh SA, Creinin MD, Archer DF, Schwartz JL, Pymar HC, Lai JJ, Rencher WF, Callahan MM; CONRAD. Mauck CK, et al. Among authors: callahan mm. Contraception. 2004 Jul;70(1):77-83. doi: 10.1016/j.contraception.2004.02.016. Contraception. 2004. PMID: 15208057 Free PMC article. Clinical Trial.

5

Fourteen-day safety and acceptability study of the universal placebo gel.

Schwartz JL, Ballagh SA, Kwok C, Mauck CK, Weiner DH, Rencher WF, Callahan MM. Schwartz JL, et al. Among authors: callahan mm. Contraception. 2007 Feb;75(2):136-41. doi: 10.1016/j.contraception.2006.09.003. Epub 2006 Oct 25. Contraception. 2007. PMID: 17241844 Clinical Trial.

6

A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet.

Ballagh SA, Brache V, Mauck C, Callahan MM, Cochon L, Wheeless A, Moench TR. Ballagh SA, et al. Among authors: callahan mm. Contraception. 2008 Feb;77(2):130-7. doi: 10.1016/j.contraception.2007.10.003. Epub 2007 Dec 27. Contraception. 2008. PMID: 18226678 Clinical Trial.

7

Six-day randomized safety trial of intravaginal lime juice.

Mauck CK, Ballagh SA, Creinin MD, Weiner DH, Doncel GF, Fichorova RN, Schwartz JL, Chandra N, Callahan MM. Mauck CK, et al. Among authors: callahan mm. J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):243-50. doi: 10.1097/QAI.0b013e318186eae7. J Acquir Immune Defic Syndr. 2008. PMID: 18845958 Clinical Trial.

8

Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study.

Mauck C, Weiner DH, Ballagh S, Creinin M, Archer DF, Schwartz J, Pymar H, Lai JJ, Callahan M. Mauck C, et al. Contraception. 2001 Dec;64(6):383-91. doi: 10.1016/s0010-7824(01)00271-2. Contraception. 2001. PMID: 11834238 Clinical Trial.

9

Safety evaluation of 1% tenofovir gel in healthy men.

Schwartz JL, Poindexter A, Wheeless A, Mauck CK, Callahan MM. Schwartz JL, et al. Among authors: callahan mm. Int J STD AIDS. 2009 Jun;20(6):384-6. doi: 10.1258/ijsa.2008.008309. Int J STD AIDS. 2009. PMID: 19451321 Clinical Trial.

10

Male tolerance study of 1% C31G.

Mauck CK, Frezieres RG, Walsh TL, Schmitz SW, Callahan MM, Bax R. Mauck CK, et al. Among authors: callahan mm. Contraception. 2004 Sep;70(3):221-5. doi: 10.1016/j.contraception.2003.12.008. Contraception. 2004. PMID: 15325891 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page